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Typically, shared decision making, with or without a decision aid, involves patients in discus-
sions about the options for treatment, the benefits and harms of each therapy, and the patient’s
preferences, and a collaborative decision about how to proceed is made. For single conditions,
that requires some motivation and teachable skills. But an additional challenge in providing
healthcare for older people is the likelihood of multimorbidity: approximately half of older
adults have 3 or more chronic conditions [1]. The patterns of comorbidity are largely deter-
mined by common conditions in older people, such as coronary heart disease, diabetes, hyper-
tension, chronic obstructive pulmonary disease (COPD), heart failure, depression, arthritis,
and cancer. Multiple conditions complicate shared decision making, as management is not the
simple sum of the parts. Should a patient with late-stage cancer continue statins? When is an
implantable defibrillator appropriate in a patient with dementia? Are beta blockers mandatory
in a patient who is depressed after a myocardial infarction? Multimorbidity is a problem itself
but also creates interactions that can generate additional problems—of particular concern are
polypharmacy and burden of treatment.
Polypharmacy
Most clinical practice guidelines focus on a single disease [2]. Applying single-disease guide-
lines for multiple conditions increases the risk of polypharmacy, which is the use of multiple
prescribed medications (sometimes defined as 5 or more) by a patient. In turn, this increases
the risk of adverse drug reactions and interactions and complicates predicting the effect of
each individual drug to compare overall benefits and harms [1,2]. The body of evidence
informing guidelines is also problematic. For example, clinical trials often do not measure the
outcomes with higher priority for many older adults, such as independent living and quality of
life [1]. Additionally, as older people are often excluded from clinical trials, evidence of the
benefits and harms of treatments and tests for this group is often limited, and trial populations
may not adequately represent community populations [3]. Guideline recommendations rarely
acknowledge such limitations or provide information about evidence uncertainty or character-
istics of the patient group upon which the evidence is based, and this hinders extrapolation [4].
Combined with clinicians’ tendency to do something rather than nothing, this contributes to
the problem of polypharmacy.
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Burden of treatment
A high ‘burden of treatment’—such as healthcare visits, refilling prescriptions, diet, and self-
managing care—on multimorbid patients is common, especially if all recommendations of
guidelines are followed. Boyd and colleagues [2] highlighted that if the care for a hypothetical
woman aged 79 years with 5 conditions (hypertension, diabetes, osteoporosis, osteoarthritis,
and chronic obstructive pulmonary disease) followed guidelines, she would be prescribed 12
medications (19 doses per day), all with their own specific instructions; have 14 nondrug tasks;
and see a variety of clinicians. Such a complex treatment plan is unlikely to be feasible, and the
hard work it requires can place a significant demand on people’s lives [2,5].
Principles for handling multimorbidity in older people
The Ariadne principles are a set of guiding principles for how to handle multimorbidity, par-
ticularly in primary care consultations, with the aim of reducing the burden of treatment and
disease [6]. At their core is the sharing of realistic treatment goals that have been collabora-
tively decided by physicians and patients. That involves 2 phases: assessing priorities and then
deciding among the management options for the highest priority problems.
Of course, for many older people, particularly those who have cognitive impairment, the
decision-making process will likely also involve family members or other informal carers.
Consultation with and communication between providers is also essential when caring for
older people with multimorbidity. There is a valuable role for generalist care, whether that be
provided by a general practitioner, geriatrician, or physician. It is important to periodically
monitor the priorities and decisions that have been made to ensure the management plan is
still of benefit to the patient, is in line with preferences and circumstances, and remains feasible
[1]. In older people with multimorbidity, circumstances and preferences can change rapidly
because of the occurrence of events such as hospitalisations [6]. A generalist can provide the
patient-centred continuity of care that situations like this require [1].
Problem prioritisation, goal setting, and shared decision making
Key to providing patient-centred care is careful and shared decision making. Problem and
decision prioritisation should involve identifying the patient’s primary concerns, priorities,
and preferences and subsequently engaging in patient-centred goal setting [1,6]. In an exami-
nation of the health outcome priorities of older adults with hypertension and fall risk, half of
the participants identified reducing the risk of cardiovascular events as more important than
reducing their combined risk of fall injuries or medication symptoms, whereas the other half
of the participants identified the opposite priorities [7].
Once goals have been collaboratively decided, the conversation shifts to the highest priority
issue and determining how this goal may best be attained. Ideally, this involves discussing the
treatment options—and, for each option, the benefits and harms (including the size or likeli-
hood of each, individualised to the patient where possible) and the practicalities and feasibility
(including the treatment burden and costs) of the options—and then, the patient’s preferences
about the options [8]. Many of these tasks are part of a process known as shared decision mak-
ing [8]. Part of the progression to making an informed choice in which the decision aligns
with the patient’s preferences and values involves the patient weighing up the likely benefit–
harm trade-off. For example, older people’s willingness to take medication for primary preven-
tion of cardiovascular disease is more sensitive to the adverse effects than it is to the benefits
[9]. There are likely to be different benefit–harm trade-offs for each individual older patient
with multimorbidity because of the heterogeneity within this group. Patients vary widely in
their health and function (both physical and cognitive), tolerance of side effects, life
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expectancy, and treatment and health outcome preferences, such as valuing length of life ver-
sus quality of life [1]. In the situation of older people with multimorbidity, among the addi-
tional knowledge and expertise that the clinician contributes to the decision-making process is
the potential for adverse drug–disease interactions and drug–drug interactions.
Barriers when using existing guidelines and decisions aids to
achieve appropriate care
Guidelines can sometimes be an obstacle in managing multimorbidity. Most existing evi-
dence and decision-support tools do not adequately facilitate shared decision making,
let alone for older people and those with multimorbidity. For example, some guidelines on
heart failure and primary cardiovascular disease prevention mostly focus on risk reduction,
without considering patients’ concerns or preferences (such as about the quality of their
remaining life) and without acknowledging the need for patient-centred goal setting
[10,11]. Related to this, guidelines typically have a strong focus on starting medication, with
limited guidance about not starting, reducing, or stopping medication (known as ‘depre-
scribing’) [10]. Guidelines often provide blanket statements around the importance of using
‘clinical judgement’ in these more complex circumstances and how ‘decisions should be
made with the patient, reflecting his or her preferences, needs, and values’ [10,12]. Most
guidelines, however, do not offer specific guidance, approaches, or tools on how to achieve
this [4,12] and are not designed in a way that optimally supports patient involvement and
shared decision making.
Patient decision aids are tools aimed at supporting the decision-making process. They typi-
cally contain synthesised information and evidence about the options, the benefits and harms,
and sometimes questions that prompt the patient to think about preferences and values. While
decision aids are available for some decisions about cardiovascular conditions, as with most
guidelines, they are not designed for people with multimorbidity. Although a systematic
review of studies evaluating the use of decision aids by older people showed that decision aids
have the potential to improve patient knowledge, risk perception, and decision participation
and decrease decisional conflict, similar to the effects of decision aids in a general population,
few decision aids are developed specifically for the elderly [13]. Consequently, most aids are
not tailored to the older patient context and do not address multimorbidity, family or carer
involvement, or the cognitive and emotional changes that might impact on decision making;
nor are they validated in older-old adults (aged>80 years) [13]. Hence, it is unclear how useful
existing decision aids are for helping clinicians to achieve shared decision making with older
people who have multimorbidity.
It is unlikely that existing approaches to developing and formatting decision aids (or a sin-
gle decision aid) could adequately incorporate the relevant evidence for multiple chronic con-
ditions, decisions, and the potential interactions and combinations. As guidelines have started
to emerge that are not about single diseases but are focussed on optimising care for people
with multimorbidity (e.g., the United Kingdom National Institute for Health and Care Excel-
lence [NICE] Guideline NG56, ‘Multimorbidity: Clinical assessment and management’), a
more flexible approach to decision-making and generic tools may also be valuable. For exam-
ple, generic versions of decision-support tools are available, such as the Ottawa Personal Deci-
sion Guide [14] (a template that prompts the clinician and patient to discuss and complete a
form with the options, their pros and cons, how much each pro or con matters to the patient,
available support, further decision-making needs, and next steps), alongside clinical encounter
tools that aim to increase patient involvement and support meaningful conversations about
goals and priorities in the context of multimorbidity [15].
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Shared decision making in older adults with multimorbidity needs a stepwise and individu-
alised approach. The sharing first needs to occur in a discussion that considers what the
patient’s priority problems and goals are so that any care provided aligns with these. For the
decisions about how to achieve the prioritised goals, the more typical ‘sharing of the decision’
about the preferred option can then occur, although existing decision aids should be used with
caution as they are unlikely to account for the increased risk of harm in older people or poten-
tial drug–drug or drug–condition interactions, and personalisation of this information is ide-
ally needed. In juggling the competing priorities and conditions (and clinicians), our aim
should be to help patients achieve their goals as much as possible while disrupting their lives as
little as possible.
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